Skip to main content

Table 2 Mean (SD) or median (interquartile interval) values of variables and variation after 9 months of lifestyle intervention according to SNP TNF −308 G/A genotypes

From: Associations of the TNF-alpha -308 G/A, IL6 -174 G/C and AdipoQ 45 T/G polymorphisms with inflammatory and metabolic responses to lifestyle intervention in Brazilians at high cardiometabolic risk

 

GG (n = 107)

AA + GA (n = 28)

 

Baseline

9 months

p

Baseline

9 months

p

Energy intake (Kcal/day)

1851.6(685.0)

1555.4(580.6)

.001

1633.6(620.9)

1449.0(488.5)

.006

Total physical activity (min/wk)

167(60, 278)

205(75, 305)

.002

140(30, 210)

210(60, 400)

.021

Weight (kg)

79.0(15.4)

77.1(15.2)

.006

76.5(16.6)

74.8(16.9)

.006

Waist circumference (cm)

99.2(12.1)

98.3(11.7)

.029

98.0(13.0)

96.9(13.6)

.205

Fasting glucose (mg/dL)

97.8(11.1)

96.2(13.1)

.233

103.9(11.2)†

97.1(9.9)

.007

Triglycerides (mg/dL)

159.1(68.0)

154.2(74.6)

.428

138.2(56.2)

141.7(61.9)

.689

Total cholesterol (mg/dL)

200.9(42.8)

197.3(43.3)

.413

202.2(47.4)

197.1(45.9)

.559

HDL-c (mg/dL)

41.7(12.3)

46.7(13.2)

.020

45.5(12.7)

46.3(10.0)

.778

LDL-c (mg/dL)

127.3(38.9)

120.1(38.2)

.097

126.8(44.6)

122.4(41.3)

.647

Apolipoprotein B (mg/dL)

95.6(22.4)

84.8(23.8)

.004

95.3(23.4)

82.5(25.5)

.004

Apolipoprotein A1 (mg/dL)

135.8(17.8)

140.8(20.1)

.005

139.7(21.7)

142.0(19.0)

.443

Insulin* (uUl/L)

9.8(6.1, 12.0)

6.9(4.3, 10.5)

.009

5.6(4.0, 10.7)†

5.2(3.1, 8.8)

.151

Adiponectin* (ng/dL)

11.8(7.5, 18.7)

16.2(11.3, 19.4)

.019

11.7(7.3, 19.1)

16.2(12.2, 20.9)

.020

Interleukin 6* (pg/dL)

2.4(1.3, 3.7)

3.2(2.0, 5.2)

.013

2.4(1.1, 4.9)

4.2(2.4, 9.4)

.006

C-reactive protein* (mg/dL)

0.37(0.19, 0.59)

0.25(0.05, 0.55)

.001

0.36(0.13, 0.94)

0.32(0.15, 0.89)

.009

TNF-α** (pg/dL)

10.8(9.0, 13.2)

8.7(7.2, 10.8)

.020

11.3(9.4, 13.9)

8.9(6.9, 10.2)

.016

  1. *log-transformed for analysis.
  2. **Non-parametric test.
  3. † p < 0.05 versus GG.
  4. TNF-α: Tumor necrosis factor alpha.